Laurie Sanders, Ph.D.

Duke University
Biomarkers
Genetics

Alexander Tropsha, Ph.D.

UNC-Chapel Hill
Biomarkers
Works in the fields of computational chemistry, cheminformatics and structural bioinformatics who works to develop new methodologies and software tools for computer-assisted drug design.

Andrew West Ph.D.

Duke University
Biomarkers
The West lab focuses on identifying critical pathogenic mechanisms underlying neurological diseases like Parkinson’s disease with the goal of developing new therapeutics to block disease progression.

James White, Ph.D., M.S.

Duke University
Biomarkers

Guorong Wu, Ph.D.

UNC-Chapel Hill
Biomarkers
Interested in discovering biomarkers across neuro-diseases, exploring how variations in the genome change the structure and development of the brain, and establishing neuro-biological basis to visualize the pathophysiological mechanisms of neuro-diseases using data-driven approach.

Ling Wu, MD, PhD

Research Assistant Professor

North Carolina Central University
Alzheimer’s Disease
Biomarkers
Cognition
REC Scholar Project: New Biomarkers for Alzheimer’s Disease and Related Tauopathies Diagnosis

Bin Xu, Ph.D.

Professor

North Carolina Central University
Biomarkers
Xu lab is interested in Molecular Medicine and Biomarker & Drug Discoveries. We focus on translational aging research and apply ultrasensitive detection technologies. Currently, we work on biomarker discovery for Alzheimer’s disease (AD) early diagnosis and differentiation between AD and related dementias, and drug discovery for AD, diabetes and obesity.